| (210) | Number of the EPO application | 15825647 |
| (220) | Filing date of the EPO application | 2015.12.23 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2023, 2023.06.07 |
| (110) | EPO patent number | 3237411 |
| (21) | Number of the application | e 2017 0233 |
| (71) | Name(s) of applicant(s), code of the country | Proteostasis Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BASTOS Cecilia M., US;
MUNOZ Benito, US;
TAIT Bradley, US; |
| (73) | Name(s) of owner(s), code of the country | Proteostasis Therapeutics, Inc., US; |
| (54) | Title of the invention | COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 413/14 (2006.01.01); A61K 31/341 (2006.01.01); A61K 31/42 (2006.01.01); A61K 31/422 (2006.01.01); C07D 405/12 (2006.01.01); C07D 407/12 (2006.01.01); C07D 409/14 (2006.01.01); C07D 413/12 (2006.01.01); C07D 417/12 (2006.01.01); C07D 261/14 (2006.01.01); C07D 307/54 (2006.01.01); A61P 11/00 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.01.31 |
| (30) | Priority | 201462096374 P, 2014.12.23, US; 201562102244 P, 2015.01.12, US; 201562196839 P, 2015.07.24, US; 201562199661 P, 2015.07.31, US |
| (86) | International application | PCT/US2015/000212, 2015.12.23 |
| (87) | International publication | WO 2016/105485, 2016.06.30 |